Published product guide
Review the guide linked from Noble Medical’s operational products page. Confirm current configurations, availability and instructions with the team before ordering.
Resource availability
The topics below are summaries for discussion. Full articles and downloadable files are not yet available in this preview. Ask the Noble team for current materials.
Spec-sheet library
Ask for the current device documentation and panel matrix. The earlier prototype lists these resources, but does not supply working PDF downloads.
- Split Specimen Cup — Spec Sheet & Panel Matrix
- Noble Drug Test Cup — Spec Sheet
- Fentanyl & Expanded Panels — Analyte List & Cut-offs
- Multi-Drug Screen Card — Spec Sheet
- T-Square & Oraliss™ Oral Fluid — Collection Guide
- Alcohol Screening — Spec Sheet
- SAMHSA Cut-off Reference Card
Panel Watch — quarterly updates
Panel, cut-off and drug-trend updates: fentanyl analogs, cut-off changes and new device clearances. Ask the team about available updates.
Need a walkthrough?
- Book training
- Request a sample
- Discuss lab confirmation with Noble Diagnostics
Common questions
What should a drug panel include?
Panels are customizable. Discuss fentanyl and, depending on the population, oxycodone, buprenorphine, tramadol or K2 with a specialist so you add what your program needs. Confirm the analytes available for your selected device.
Oral fluid vs. urine — which should we use?
Urine cups offer a range of panel options. Oral-fluid devices support observed collection with minimal facilities. Compare specimen type, collection workflow and available panels with a specialist before selecting the format.
What does CLIA-waived actually mean?
Ask for the selected device's current regulatory documentation and instructions, and confirm the requirements that apply to your testing setting. Regulatory status is device-specific; a general product-family description is not a substitute for that review.
How do cut-off levels work?
A cut-off is the concentration at which a device reports a negative or non-negative screening result. Ask for the current analyte list and cut-offs for the specific device and panel you plan to use.
What happens when a rapid test is non-negative?
A rapid device screens; it does not confirm. Discuss lab confirmation through Noble Diagnostics, chain-of-custody and result review with your program's qualified reviewer before making decisions based on a screening result.
Can we customize panels or private-label?
Yes — customization is the core of what we do. Build the exact panel configuration your program needs, and distributors can discuss private-label runs with their own branding. Talk to a rep about minimums and lead times.